P6562Cerium (IV) oxide nanoparticles reduce platelet aggregation through suppression of cellular ROS production and VEGF secretion

2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
D Labudzynskyi ◽  
D Zhernosekov ◽  
N Zholobak ◽  
A Obrosov ◽  
A Tykhomyrov
1975 ◽  
Vol 13 (11) ◽  
pp. 41-43

Two preparations of dextran have been tried for prevention of venous thromboembolic disease, dextran-40 (average m. w. 40,000) and dextran-70 (average m.w. 70,000). Dextrans reduce platelet aggregation and lower blood viscosity.1 Dextran may also reduce the peri-operative rise in the coagulation factors V and VIII.2 However, in some tests dextrans increase platelet aggregation3 and accelerate fibrin formation,4 so that only clinical trial can show whether dextran reduces the incidence of either deep-vein thrombosis or of pulmonary embolism.


2020 ◽  
pp. 088532822097909
Author(s):  
Tingting Liu ◽  
Shiqian Han ◽  
Mao Pang ◽  
Jing Li ◽  
Jing Wang ◽  
...  

Heat stroke and severe fever cause anemia, although the underlying mechanism remains unclear. Here, we report the use of Cerium oxide nanoparticles in protection of red blood cells against damage caused by exposure to short-term hyperthermia (42°C, 10 min). Red blood cells exposed to hyperthermia exhibited extradition senescence with higher density, smaller size and lower zeta potential relative to those under normal physiological environment (37°C, 10 min). Furthermore, hyperthermia-exposed cells exhibited significantly higher reactive oxygen species (ROS) production compared to the normal conditions. Importantly, the preconditional treatment, using Ceria nanoparticles (CNPs), ameliorated senescence and apoptosis in red blood cells damaged by hyperthermia by reducing ROS levels. Summarily, short-term hyperthermia caused a significant increase in ROS in red blood cells, and resulted in senescence and apoptosis. These may be possible mechanisms of pathological changes in red blood cells exposed to heat stroke or severe fever. Overall, these findings indicate that CNPs strongly inhibit ROS production, and effectively ameliorates hyperthermia-induced damages in red blood cells.


2012 ◽  
Vol 8 (10) ◽  
pp. 3832-3839 ◽  
Author(s):  
Mark Geppert ◽  
Michaela C. Hohnholt ◽  
Sylvia Nürnberger ◽  
Ralf Dringen

2021 ◽  
Vol 23 (4) ◽  
pp. 647-652
Author(s):  
S. V. Uzhviyuk ◽  
M. S. Bochkova ◽  
V. P. Timganova ◽  
P. V. Khramtsov ◽  
K. Yu. Shardina ◽  
...  

Graphene-based materials have an opportunity for use in biomedicine, thanks to their properties. Nevertheless, due to its cytotoxic effects, the use of graphene-based drugs is problematic. However, the surface modification of graphene oxide (GO) nanoparticles with a polyethyleneglycol (PEG) is one way to reduce the harmful effects of graphene on cells. Applying nanoparticles implies their interaction with the immune system, which protects the body. Monocytes are innate immunity cells and the first line of defenсe of the human organism from microorganisms and other alien objects. One of the monocytes’ reactions to a stimulus of any nature is to produce reactive oxygen species (ROS). Published data shows an incomplete picture of modified graphene oxide nanoparticles’ effects on ROS formation by human monocytes. Thus, it was essential to evaluate the pegylated graphene oxide (GO-PEG and GO-8armedPEG) effect on ROS production by human monocytes, assessed by the luminol-dependent chemiluminescence (LCL). The objects of the study were CD14+-cells isolated from mononuclear cells of healthy donors. ROS production was stimulated by opsonized zymosan (OZ), spontaneous LCL was used as a control. PEG-modified (GO-PEG and GO-8armedPEG) GO nanoparticles with sizes of 100-200 nm (“small”) and 1-5 μm (“big”) with PEG covering ~ 20% were used at concentrations of 5 and 25 μg/ml. The study showed that small size nanoparticles at a low concentration of 5 μg/ml and big nanoparticles coated with 8-armed PEG at both concentrations have a significant suppressive effect on spontaneous ROS production. In the stimulated LCL reaction variant, it was found that small nanoparticles (25 μg/ml) also have a suppressive effect on ROS production, such as big-sized particles coated with linear PEG at the same concentration. Thus, we have established for the first time that graphene oxide nanoparticles functionalized with PEG are capable of inhibiting the ROS production by human monocytes, and therefore, we can speak of the antioxidant activity of GO-PEG. 


2004 ◽  
Vol 5 (1) ◽  
pp. 12
Author(s):  
B. Lutters ◽  
T. Molenaar ◽  
S. Korporaal ◽  
J. Akkerman ◽  
T. van Berkel ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (19) ◽  
pp. 5735
Author(s):  
Maria Grazia Signorello ◽  
Federica Rapetti ◽  
Elda Meta ◽  
Adama Sidibè ◽  
Olga Bruno ◽  
...  

(1) Background: different previously synthesized pyrazoles and imidazo-pyrazoles showed interesting anti-angiogenic action, being able to interfere with ERK1/2, AKT and p38MAPK phosphorylation in different manners and with different potency; (2) Methods: here, a new small compound library, endowed with the same differently decorated chemical scaffolds, has been synthetized to obtain new agents able to inhibit different pathways involved in inflammation, cancer and human platelet aggregation. (3) Results: most of the new synthesized derivatives resulted able to block ROS production, platelet aggregation and p38MAPK phosphorylation both in platelets and Human Umbilical Vein Endothelial cells (HUVEC). This paves the way for the development of new agents with anti-angiogenic activity.


Sign in / Sign up

Export Citation Format

Share Document